e-learning
resources
Virtual 2021
07.09.2021
Imaging in COVID-19
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Calculating expected lung lesion volume in patients with COVID-19.
S. Goponiako (Gomel, Belarus), I. Buinevich (Gomel, Belarus), K. Levchenko (Gomel, Belarus)
Source:
Virtual Congress 2021 – Imaging in COVID-19
Session:
Imaging in COVID-19
Session type:
E-poster
Number:
3239
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Goponiako (Gomel, Belarus), I. Buinevich (Gomel, Belarus), K. Levchenko (Gomel, Belarus). Calculating expected lung lesion volume in patients with COVID-19.. 3239
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
A comparison between total lung capacity and effective alveolar volume in patients with restrictive lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 180s
Year: 2005
Selection of patients for lung volume reduction surgery
Source: Eur Respir J 2002; 20: Suppl. 38, 606s
Year: 2002
Accuracy of the calculated estimated postoperative pulmonary function (CEPPF) in lung cancer patients
Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies
Year: 2007
The outcome of patients with COPD selected for a lung volume reduction surgery
Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases
Year: 2009
Physiological consequence of lower vs upper lobe lung volume reduction in patients with advanced emphysema
Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction
Year: 2011
Possibility of lung volume reduction surgery in high risk patients
Source: Annual Congress 2009 - Current challenges in thoracic surgery
Year: 2009
Differences in the pattern of FEV1 and VC change after lung resection between lung cancer patients with limited and normal lung function
Source: Eur Respir J 2006; 28: Suppl. 50, 278s
Year: 2006
Unilateral lung volume reduction surgery in patients with homogenous distribution of pulmonary emphysema
Source: Eur Respir J 2005; 26: Suppl. 49, 491s
Year: 2005
Lung expansion and alternation of low attenuation volume in lobectomized patients.
Source: Virtual Congress 2020 – Thoracic surgery: malignancies
Year: 2020
Can we predict success of lung volume reduction surgery?
Source: Eur Respir J 2004; 24: Suppl. 48, 237s
Year: 2004
The effect of endoscopic lung volume reduction on functional outcomes in patients with severe emphysema.
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019
Changes in resting metabolic rate in patients with severe emphysema after lung volume reduction surgery
Source: Eur Respir J 2003; 22: Suppl. 45, 369s
Year: 2003
Effect of endoscopic lung volume reductions in patients with emphysema – a single center experience
Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD
Year: 2018
Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema
Source: Eur Respir J 2006; 28: Suppl. 50, 98s
Year: 2006
Long-term follow-up after bronchoscopic lung volume reduction in patients with emphysema
Source: Eur Respir J 2012; 39: 1084-1089
Year: 2012
Comparison of two methods for estimating the predicted postoperative (PPO) lung function after lung cancer resection in COPD patients
Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases
Year: 2009
MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension.
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021
Ventilation Heterogeneity in Asthma and COPD. The value of the poorly communicating fraction, as the ratio of total lung capacity to alveolar volume.
Source: Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD
Year: 2021
The lung volume reduction surgery: functional outcome with different level of airways obstruction
Source: Annual Congress 2004 - Lung volume reduction surgery and pneumothorax
Year: 2004
Short term outcome of lung volume reduction with endobronchial valves in emphysema patients with a very low diffusion capacity
Source: International Congress 2019 – Bronchoscopic treatment of COPD: hot news
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept